Minneapolis Clinical Trials

2015 Study (Renal)

The purpose of Study 2015 is to evaluate the safety, tolerability and pharmacokinetics of an investigational medication in those with varying degrees of renal impairment

5 nights
1 visits

During Study 2015, participants will receive a single oral dose of the investigative treatment.

Compensation for study participation may be provided for time and travel up to $1,700.

This study has been approved by an independent ethics committee.

Call Jenna at 651-724-0500 or register your interest to discuss your eligibility today!


Biological Sex Females with renal impairment
Age 18 - 75 years old
BMI 18.5 - 36
Medication Medications and conditions stable in the opinion of the investigator